Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 482.30
+5.30 (1.11%)
Oct 30, 2026, 4:59 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 108.6 billion as of October 30, 2026. It is the 1,410th most valuable company in the world and the 10th biggest in Denmark. Its market cap has decreased by 18.75% in one year.
Market Cap
108.60B
Enterprise Value
131.58B
Revenue
28.44B
Global Rank
Country Rank
#10 Denmark
PE Ratio
39.34
ChartMarket Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 108.60B, an increase of 1,746.91%. That is a compound annual growth rate of 10.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 108.60B | -11.81% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.18T |
| Genmab | 233.76B |
| Demant | 77.06B |
| ALK-Abelló | 55.03B |
| H. Lundbeck | 53.17B |
| Ambu A/S | 21.20B |
| Bavarian Nordic | 18.58B |
| Zealand Pharma | 15.95B |